Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Colorectal cancer (CRC) development is characterized by the stepwise accumulation of mutations over time, of which mutations in the tumor suppressor APC are often very early to occur.
|
30799131 |
2020 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The expression levels of miR31, miR92a, KRAS oncogene, and the c-MYC transcription factor were subexpressed upon 72 h post-treatment with kaempferol-3-<i>O</i>-glycoside compared with the control without treatment (<i>P</i> < .05); in contrast, the tumor suppressor genes AMPK (∼4.85, <i>P</i> = .005) and APC (∼2.71, <i>P</i> = .066) tumor suppressors genes were overexpressed.
|
31441682 |
2020 |
Neoplasms
|
0.200 |
PosttranslationalModification
|
group |
BEFREE |
But no correlation was found between APC promoter methylation and age, lymph node status, and tumor number (P > 0.1).
|
30868894 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Tumor clones present within the PPTID metastases but not the pineal midline tumor harbored mutations in APC and TIMP2.While the majority of H3K27M mutations are found in pediatric midline gliomas, it is increasingly recognized that this mutation is present in a wider range of lesions with a varied morphological appearance.
|
31653819 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Familial adenomatous polyposis (FAP) is an autosomal dominant syndrome associated with mutation in the adenomatous polyposis coli (APC) gene, a tumour suppressor located on chromosome 5q21.
|
31712236 |
2019 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
APC negatively regulates the Wnt signaling pathway by promoting the degradation of β-catenin, but the extent to which APC exerts Wnt/β-catenin-independent tumor-suppressive activity is unclear.
|
31160382 |
2019 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
APC is lost in a subset of pancreatic cancers, but the impact on Wnt signaling or tumor development is unclear.
|
31540078 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
In approximately 1% of the cases we identify insertions in APC, likely to be tumor-initiating events.
|
31492840 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Regarding qualitative imaging features, on univariate analysis, tumor location was significantly associated with APC (p = 0.032) and RASA1 mutation (p = 0.032); CRM status was significantly associated with ATM mutation (p = 0.021); and lymph node metastasis was significantly associated with BRCA2 (p = 0.046) mutation.
|
30927944 |
2019 |
Neoplasms
|
0.200 |
AlteredExpression
|
group |
BEFREE |
GSEA demonstrated a strong association between duodenal adenoma/adenocarcinomas with colorectal adenomas (p < 10<sup>-5</sup>) and gene expression patterns seen after APC gene knockout (p < 10<sup>-5</sup>), suggesting that the Wnt/β-catenin pathway plays a crucial role in the carcinogenesis of these neoplasms.
|
29951927 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Since the APC product interacts with beta-catenin, APC variants may, in addition to CTNNB1, contribute to the pathogenesis of solid pseudopapillary neoplasms via the Wnt signaling pathway.
|
30811747 |
2019 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
Then, RT-qPCR and dual luciferase assay showed that miR-942 upregulated Wnt signaling through direct targeting of APC, which is a tumor suppressor in Wnt signaling pathway.
|
31278963 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
The unusual morphology prompted molecular characterization, and sequencing demonstrated the patient to be germline heterozygous for a 5-base-pair APC deletion at codon 1309 with loss of heterozygosity in the tumor.
|
30172912 |
2019 |
Neoplasms
|
0.200 |
AlteredExpression
|
group |
BEFREE |
In gain-of-function experiments, ectopic expression of circ-APC inhibited DLBCL cell proliferation <i>in vitro</i> and tumor growth <i>in vivo</i>.
|
31631067 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Immunohistochemical detection of ALK protein identifies APC mutated medulloblastoma and differentiates the WNT-activated medulloblastoma from other types of posterior fossa childhood tumors.
|
30523493 |
2019 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
Here we examine the requirement of BCL9/9l, constituents of the Wnt-enhanceosome, for intestinal transformation following loss of the tumour suppressor APC.
|
30760720 |
2019 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
IMPLICATIONS: Our findings demonstrate how the activity of the APC/C<sup>CDH1</sup> tumor suppressor is reduced in CSCs and also validates small-molecule inhibition of the APC/C as a promising therapeutic target for the treatment of GBM.
|
31036696 |
2019 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
The key point of this model is the mutation of Apc gene, which is a significant tumor-suppressor gene in the Wnt signaling pathway.
|
30887153 |
2019 |
Neoplasms
|
0.200 |
PosttranslationalModification
|
group |
BEFREE |
Whereas APC methylation in EC was similar to that in BE (<i>P</i> = 0.052), it was not associated with tumor stage (<i>P</i> = 0.204).
|
29440928 |
2018 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
Altered Wnt-signaling associated genes, apart from APC, may act as potential drivers of these neoplasms.
|
29327707 |
2018 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
After extraction of tumor DNA, we used a platform designed to detect approximately 3,000 somatic hotspot variants in 55 genes (including KRAS, APC, CTNNB1, and TP53).
|
29758216 |
2018 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The tumor suppressors APC and Axin form the core of the multiprotein destruction complex, which targets the Wnt-effector beta-catenin for phosphorylation, ubiquitination and destruction.
|
29641560 |
2018 |
Neoplasms
|
0.200 |
GeneticVariation
|
group |
BEFREE |
Moderate impact APC mutations and non-APC-related causes of increased WNT signaling may have a more important role in serrated neoplasia than the truncating APC mutations common in conventional adenomas.
|
29148535 |
2018 |
Neoplasms
|
0.200 |
AlteredExpression
|
group |
BEFREE |
Based on published and our data we propose that K-ras could be the oncogene responsible for the inactivation of the tumor-suppressor gene APC, currently considered as the initial step in colorectal tumorigenesis.
|
28652417 |
2018 |
Neoplasms
|
0.200 |
Biomarker
|
group |
BEFREE |
The incidence rates increased for tongue-base tumors (APC 1.17, 95% CI 0.42 to 1.92) and tonsil tumors (APC 0.47, 95% CI 1.10 to 4.96) but decreased for other sites.
|
29086431 |
2018 |